DMA Amylase (Demand) Procedure
by Data Medical Associates, Inc. 510(k)
Active
510(k) K940010
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK940010 | Date11 Mar 1994 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 6 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- CIJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1070
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
The DMA Amylase (Demand) Procedure is a saccharogenic amylase device used in clinical chemistry. It is classified as a Class II medical device under regulation number 862.1070.
The device received FDA 510(k) clearance (K940010) on March 11, 1994, following a traditional review process. It was found substantially equivalent to a predicate device and is manufactured by Data Medical Associates, Inc. The product code is CIJ, and it falls under the clinical chemistry medical specialty.
Other devices from Data Medical Associates, Inc.
Questions
AI-generated answers, 22 Sep 2026
What is the DMA Amylase (Demand) Procedure used for?
The DMA Amylase (Demand) Procedure is a saccharogenic amylase device used in clinical chemistry to measure amylase enzyme activity, which aids in diagnosing conditions such as pancreatitis or salivary gland disorders by detecting elevated levels in biological fluids.
How is the DMA Amylase (Demand) Procedure supplied and is it sterile or single-use?
The device data does not specify supply format, sterility, or single-use/reuse status; therefore, no details about packaging, sterilization method, or intended use duration can be confirmed from the provided information.
What regulatory pathway was used for the DMA Amylase (Demand) Procedure and when was it cleared?
The DMA Amylase (Demand) Procedure received FDA 510(k) clearance through a traditional review process on March 11, 1994, under K940010, after being determined substantially equivalent to a legally marketed predicate device.